Skip to content

Effects of D-allulose (D-psicose), rare sugar, on postprandial energy expenditure in healthy humans

Effects of D-allulose (D-psicose), rare sugar, on postprandial energy expenditure in healthy humans - Effects of D-allulose on postprandial energy expenditure in healthy humans

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016365
Enrollment
6
Registered
2015-01-30
Start date
2013-07-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Intake of aspartame dissolved in water Intake of D-allulose (D-psicose) dissolved in water

Sponsors

Matsutani Chemical Industry Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Healthy adults 2) Subjects giving written informed consent

Exclusion criteria

Exclusion criteria: 1) Subjects who have allergic reaction to medicine 2) Subjects who smoke excessively and drink alcohol habitually, and whose eating habits are extremely irregular 3) Subjects who have liver dysfunction or renal dysfunction 4) Subjects who have history of surgery on gastrointestinal part such as gastrectomy, gastrointestinal suture and intestinal resection 5) Midnight and irregular shift worker 6) Subjects who regularly use drugs such as constipation drugs, gastrointestinal drugs and intestinal drugs 7) Subjects who regularly have dietary fiber or oligosaccharides enriched food 8) Subjects who have diarrhea 9) Subjects who have diseases such as peptic ulcer, ulcerative colitis and irritable bowel syndrome 10) Subjects who are during pregnancy or nursing

Design outcomes

Primary

MeasureTime frame
Energy expenditure and substrate utilization assessed from respiratory gas analysis

Countries

Japan

Contacts

Public ContactKimura Tomonori

Matsutani Chemical Industry Co., Ltd. Research and Development Department

tomonori-kimura@matsutani.co.jp072-771-2032

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026